Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure.
暂无分享,去创建一个
[1] B. Holman,et al. A simplified technique for measuring right ventricular ejection fraction using the equilibrium radionuclide angiocardiogram and the slant-hole collimator. , 1981, Radiology.
[2] J. Cohn,et al. Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure. , 1980, The American journal of cardiology.
[3] E. Braunwald,et al. Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.
[4] L. Johnson,et al. Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. , 1980, The American journal of medicine.
[5] L. Johnson,et al. Right ventricular ejection fraction during exercise in patients with coronary artery disease. , 1979, Circulation.
[6] C. Conti,et al. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure. , 1979, British heart journal.
[7] D. Berman,et al. A New Technique for Assessing Right Ventricular Ejection Fraction Using Rapid Multiple‐gated Equilibrium Cardiac Blood Pool Scintigraphy: Description, Validation and Findings in Chronic Coronary Artery Disease , 1979, Circulation.
[8] J. Ruskin,et al. Primary pulmonary hypertension treated with oral phentolamine. , 1979, Annals of internal medicine.
[9] W. Pettinger,et al. Drug therapy. Prazosin. , 1979, The New England journal of medicine.
[10] W. Aronow,et al. Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.
[11] J A Parker,et al. Ejection fraction image: a noninvasive index of regional left ventricular wall motion. , 1978, The American journal of cardiology.
[12] R. Matthay,et al. Assessment of cardiac performance with quantitative radionuclide angiocardiography: right ventricular ejection fraction with reference to findings in chronic obstructive pulmonary disease. , 1978, The American journal of cardiology.
[13] J. A. Thomas,et al. Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.
[14] R. Miller,et al. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.
[15] B. Massie,et al. Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.
[16] J. Cohn,et al. Treatment of refractory heart failure with infusion of nitroprusside. , 1974, The New England journal of medicine.
[17] P. Kadowitz,et al. Effect of Sympathetic Nerve Stimulation on Pulmonary Vascular Resistance in the Dog , 1973, Circulation research.
[18] D. Ramsay,et al. The site of action of nerves in the pulmonary vascular bed in the dog , 1970, The Journal of physiology.
[19] Y. Yoshida. Studies on the pathologic physiology of pulmonary hypertension in mitral valvular disease. 1. The role of sympathetic nervous system on the increment of pulmonary vascular resistance. , 1969, Japanese circulation journal.
[20] Y. Yoshida. Studies on the pathologic physiology of pulmonary hypertension in mitral valvular disease-1,2- , 1969 .
[21] 吉田 浩. Studies on the pathologic physiology of pulmonary hypertension in mitral valvular disease , 1969 .
[22] G. Bousvaros. EFFECTS OF NOREPINEPHRINE ON HUMAN PULMONARY CIRCULATION , 1962, British heart journal.
[23] D. J. Patel,et al. Some Evidence for Active Constriction in the Human Pulmonary Vascular Bed , 1958, Circulation.